Screener
Charles River Laboratories CRL Manufacturing — Intangible asset impairment
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:ImpairmentOfIntangibleAssetsFinitelived.
The source filing: Charles River Laboratories’s 10-K, filed February 18, 2026.
- Filed
- Feb 18, 2026, 9:21 AM EST
- Fiscal year
- FY2025
- Accession
- 0001100682-26-000022
| Line item | Fiscal Year / December 27, 2025 | Fiscal Year / December 28, 2024 | Fiscal Year / December 30, 2023 |
|---|---|---|---|
| Cost of revenue (excluding amortization of intangible assets) | 429,840 | 440,511 | 441,411 |
| Selling, general and administrative | 142,101 | 132,803 | 146,311 |
| Amortization of intangible assets | 104,778 | 52,471 | 45,392 |
| Intangible asset impairment | 108,974 | — | — |
| Goodwill impairment | 165,000 | 215,000 | — |
| Operating income (loss) | $(184,284) | $(71,453) | $88,329 |
| Unallocated Corporate (1) | |||
| Selling, general and administrative | $259,676 | $258,121 | $231,810 |
Item 8. Financial Statements and Supplementary Data
FAQ
- What is Charles River Laboratories's manufacturing — intangible asset impairment?
- Charles River Laboratories (CRL) reported manufacturing — intangible asset impairment of $27.24M in Q4 2025.
- What does manufacturing — intangible asset impairment mean?
- Charges recognized when the carrying amount of intangible assets within the manufacturing segment exceeds their recoverable amount. This reflects a decline in the value of assets such as patents, licenses, or customer relationships.
Ask your AI about Charles River Laboratories's manufacturing — intangible asset impairment.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude